Corneal neovascularization is defined as the appearance of vessels within the normally avascular corneal stroma. It is the end stage of most inflammatory diseases of the anterior segment. In recent years, several studies have shown encouraging results in the treatment of corneal neovessels by anti-VEGF.
We conducted a prospective study in ophthalmology B, based on the study of the efficacy and tolerance of intra-stromal injections of bevacizumab in 10 patients with corneal neovessels with a follow-up of 6 months.